Masebole Masenya to Rifampin
This is a "connection" page, showing publications Masebole Masenya has written about Rifampin.
Connection Strength
0,325
-
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial. J Antimicrob Chemother. 2021 11 12; 76(12):3237-3246.
Score: 0,174
-
Pharmacokinetics and safety of a raltegravir-containing regimen in HIV-infected children aged 2-12 years on rifampicin for tuberculosis. AIDS. 2019 11 15; 33(14):2197-2203.
Score: 0,151